Dr. Michael Alexandre Fernandes, MD

Dr. Fernandes practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.

Dr. Fernandes' NPI, 1861656076, was assigned on July 16, 2008. Dr. Fernandes holds Pennsylvania license MD452506.

Dr. Fernandes' primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.

Dr. Fernandes' primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dr. Fernandes is also affiliated with Christiana Hospital. The medical group on file is Trinity Health Mid-Atlantic Medical Group. Dmand AI also links Dr. Fernandes to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fernandes practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Fernandes' primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Fernandes' licenses on file in 2 states: Pennsylvania and New Jersey.

CMS data shows 259 Medicare services from Dr. Fernandes across 3 procedure codes in 2024, for 259 Medicare patients. Medicare paid $34,402 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 259 Medicare patients who saw Dr. Fernandes in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fernandes' median patient age at 43, with 47% women.

In 2024, Dr. Fernandes wrote 89 Medicare Part D claims for 63 patients. 97% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $166 in total drug cost. In 2019, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Fernandes for performance year 2024, reported as part of a group. Dr. Fernandes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Fernandes, published from 2016 to 2019. 2019 was the busiest year, with 4. The most frequent topics are Neoplasm Metastasis, Blood Pressure and Cardiovascular Diseases. Dr. Fernandes has published most often in Lancet Oncol.

CMS Open Payments shows 20 general payments to Dr. Fernandes from 1 drug or device company from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $354.